Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group

2019/01/16 by Uma Mahadevan, Christopher Robinson, Nana Bernasko +13 · 25 citations
Medicine · Immunology and Microbiology · #Pregnancy and Medication Impact #Eosinophilic Esophagitis #Reproductive System and Pregnancy

paper · pdf · doi:10.1053/j.gastro.2018.12.022

Cited by

• Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric. [europepmc]
• Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions. [europepmc]
• Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease. [europepmc]
• JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications. [europepmc]
• Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. [europepmc]
• Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. [europepmc]
• Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature. [europepmc]
• Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease. [europepmc]
• Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. [europepmc]
• Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease. [europepmc]
• Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. [europepmc]
• The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding. [europepmc]
• Use of thiopurines in inflammatory bowel disease: an update. [europepmc]
• Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society. [europepmc]
• IBD in pregnancy: recent advances, practical management. [europepmc]
• Review of pregnancy in Crohn's disease and ulcerative colitis. [europepmc]
• The use and impact of monoclonal antibody biologics during pregnancy. [europepmc]
• Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study. [europepmc]
• How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease. [europepmc]
• Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review. [europepmc]
• A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease. [europepmc]
• Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars. [europepmc]
• Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase ® ). [europepmc]
• Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn's Disease and 2 Years in Ulcerative Colitis. [europepmc]
• Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis. [europepmc]